Articles From: Pfizer confirms it approached AstraZeneca twice to Phoenix New Media to Attend Upcoming Investor Conferences


MADRID (MarketWatch) -- U.S. pharmaceutical group Pfizer Inc. (PFE) on Monday confirmed that it has made a fresh approach to AstraZeneca PLC (uk:azn)(AZN) over a tie-up.
Sign-up for Pfizer confirms it approached AstraZeneca twice investment picks
By Hester Plumridge LONDON --
Sign-up for Pfizer details AstraZeneca bid for U.K. lawmakers investment picks
NEW YORK (MarketWatch) -- Pfizer Inc. (PFE) said Monday its first-quarter earnings fell to $2.33 billion, or 36 cents a share, from $2.75 billion, or 38 cents a share in the year-earlier period.
Sign-up for Pfizer first-quarter revenue misses expectations investment picks
2014/5/9
By Laura Saunders and Jonathan D.
Sign-up for Pfizer holders could face tax hit in AstraZeneca deal investment picks
2014/4/28
Pfizer Inc. will hold analyst and investor calls to discuss its continuing interest in a possible merger transaction with AstraZeneca Plc.
Sign-up for Pfizer Invites Investors, Analysts And Media To Join Conference Calls Discussing Possible Combination With AstraZeneca investment picks
NEW YORK (MarketWatch) -- Pfizer Inc. (PFE) is planning to make an improved offer for AstraZeneca PLC (AZN), according to The Wall Street Journal, citing people familiar with the matter.
Sign-up for Pfizer planning to make new AstraZeneca bid: WSJ investment picks
By Jonathan D.
Sign-up for Pfizer raises offer for AstraZeneca investment picks
LONDON (MarketWatch) -- U.S. pharmaceutical giant Pfizer Inc. (PFE) indicated on Tuesday it would raise its offer for AstraZeneca PLC (uk:azn)(AZN) for a second time.
Sign-up for Pfizer readies higher price for AstraZeneca investment picks
By Jonathan D.
Sign-up for Pfizer resumes takeover talks with AstraZeneca: WSJ investment picks
By Hester Plumridge LONDON --
Sign-up for Pfizer willing to revamp AstraZeneca takeover bid investment picks
http://media.marketwire.com/attachments/201309/183468_PFSWLogos.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1116892&ProfileId=051205&sourceType=1 ALLEN, TX --
Sign-up for PFSweb to Present at the 11th Annual Craig-Hallum Institutional Investor Conference on May 28, 2014 investment picks
SAN FRANCISCO , May 1, 2014 /PRNewswire/ -- PG&E Corporation's (NYSE: PCG) news release disclosing its first-quarter 2014 financial results has been furnished this morning to the U.S. Securities and Exchange Commission (SEC) ( http://www.sec.gov/edgar.shtml ) and is now available on PG&E Corporation's website at http://www.pgecorp.com/news/press_releases/Release_Archive2014/140501press_release.shtml .
Sign-up for PG&E Corporation Releases First-Quarter 2014 Results investment picks
2014/5/12
Investing about $6 Billion a Year to Meet Customer Needs SAN FRANCISCO , May 12, 2014 /PRNewswire/ -- Pacific Gas and Electric Company (PG&E) is committed to building on its progress in improving the safety and reliability of its service as it lays the foundation for meeting customers' future energy needs, the company said today at PG&E's annual shareholders meeting.
Sign-up for PG&E Pledges Continued Focus on Safe, Reliable, Affordable Service investment picks
PG&E Earns #1 Spot in Solar Industry Report for the Sixth Year in a Row SAN FRANCISCO , May 1, 2014 /PRNewswire/ -- Pacific Gas and Electric Company (PG&E) has been recognized by the Solar Electric Power Association (SEPA) as a national leader in solar power.
Sign-up for PG&E Recognized as National Leader in Solar Power investment picks
N. VENICE, Fla., May 9, 2014 (GLOBE NEWSWIRE) -- PGT, Inc. (Nasdaq:PGTI) , the nation's leading manufacturer and supplier of residential impact-resistant windows and doors, announced this week that its Board of Directors has appointed Brad West, 44, as Chief Financial Officer, effective June 1, 2014.
Sign-up for PGT Industries Appoints Brad West as New Chief Financial Officer investment picks
N. VENICE, Fla., May 1, 2014 (GLOBE NEWSWIRE) -- PGT Industries (Nasdaq:PGTI) , the nation's leading manufacturer and supplier of residential impact-resistant windows and doors, announced today that it will become a component in the S&P SmallCap 600® index after the close of trading on Friday, May 2, 2014.
Sign-up for PGT Industries Set to Join the S&P SmallCap 600 investment picks
VENICE, Fla., May 7, 2014 (GLOBE NEWSWIRE) -- PGT, Inc. (Nasdaq:PGTI) , the leading U.S. manufacturer and supplier of residential impact-resistant windows and doors, announces financial results for its first quarter ended March 29, 2014.
Sign-up for PGT Reports 2014 First Quarter Results investment picks
VENICE, Fla., April 10, 2014 (GLOBE NEWSWIRE) -- PGT, Inc. (Nasdaq:PGTI) will host a conference call on Thursday, May 8, 2014, to discuss the company's first quarter results, as well as other business matters.
Sign-up for PGT, Inc. Announces 2014 First Quarter Results Conference Call investment picks
N. VENICE, Fla., April 23, 2014 (GLOBE NEWSWIRE) -- PGT Industries (Nasdaq:PGTI) , the nation's leading supplier of residential impact-resistant windows and doors announced today the release of newly designed sales and marketing materials.
Sign-up for PGT(R) Releases New Marketing Materials for All Product Lines investment picks
SUNNYVALE, Calif.
Sign-up for Pharmacyclics appoints Gregory R. Wade to lead Business Development investment picks
NATICK, Mass., April 24, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) , a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, today announced the initiation of a Phase 2 trial of its novel, oral Selective Inhibitor of Nuclear Export (SINE) compound Selinexor (KPT-330) in patients with advanced gynecologic malignancies including cervical, ovarian and uterine carcinomas.
Sign-up for Phase 2 Study of Selinexor (KPT-330) Initiated by Karyopharm in Patients With Advanced Gynecologic Malignancies (SIGN Study) investment picks
NATICK, Mass., April 29, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) , a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, today announced the initiation of a Phase 2 trial of its novel, oral Selective Inhibitor of Nuclear Export (SINE) compound Selinexor (KPT-330) in patients with glioblastoma following treatment with radiation and temozolomide.
Sign-up for Phase 2 Study of Selinexor (KPT-330) Initiated by Karyopharm in Patients With Recurrent Glioblastoma After Failure of Radiation and Temozolomide (KING Study) investment picks
TEANECK, N.J., May 13, 2014 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (Nasdaq:PAHC) today reported its financial results for its March 2014 fiscal third quarter and provided guidance for its June 2014 fiscal fourth quarter and fiscal year.
Sign-up for Phibro Animal Health Corporation Reports Third Quarter Results investment picks
TEANECK, N.J., May 2, 2014 (GLOBE NEWSWIRE) -- (Nasdaq:PAHC) --Phibro Animal Health Corporation will host a webcast and conference call to review third quarter fiscal 2014 financial results.
Sign-up for Phibro Animal Health Corporation to Host Webcast and Conference Call on March 2014 Quarterly Financial Results investment picks
2014/4/30
Regulatory News: Philip Morris International Inc. (NYSE / Euronext Paris: PM) will host a live audio webcast of its 2014 Annual Meeting of Shareholders at www.pmi.com/webcasts on Wednesday, May 7, 2014 at 9:00 a.m. ET.
Sign-up for Philip Morris International Inc. to Host Webcast of 2014 Annual Meeting of Shareholders investment picks
2014/5/16
Philips Hospital to Home executives and customers to share telehealth successes and highlight clinical programs across the continuum of care ANDOVER, Mass.
Sign-up for Philips Drives Discussion at American Telemedicine Association Conference investment picks
2014/5/19
Extension of eCareManager platform into eAcute clinical program drives further adoption of telehealth in medical and surgical care settings ANDOVER, Mass.
Sign-up for Philips Hospital to Home Continues to Advance Integrated Telehealth Solutions Across Care Continuum investment picks
- New hospital site for Karolinska in Solna, Sweden will have access to state-of-the art imaging solutions and services for a 14-year term at predictable costs - Agreement includes research and innovation collaboration that unites researchers from industry, hospital and academia SOLNA, Sweden , May 7, 2014 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has signed a partnership agreement with the Stockholm County Council (SCC) to jointly innovate in health care.
Sign-up for Philips partners with the Stockholm County Council and Karolinska University Hospital to meet future demands of health care investment picks
NEW YORK (MarketWatch) -- Phillips 66 (PSX) on Wednesday reported first-quarter earnings of $1.6 billion, or $2.67 a share, versus $1.4 billion, or $2.23 a share in the same period a year earlier.
Sign-up for Phillips 66 tops earnings forecast investment picks
BEIJING , May 15, 2014 /PRNewswire/ -- Phoenix New Media Limited (NYSE: FENG) , a leading new media company in China ("Phoenix New Media", "PNM" or the "Company"), today announced its participation in the following conferences: The 5 th dbAccess Asia Conference 2014, to be held May 19 - 23, 2014 at the Marina Bay Sands in Singapore .
Sign-up for Phoenix New Media to Attend Upcoming Investor Conferences investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Pfizer confirms it approached AstraZeneca twice to Phoenix New Media to Attend Upcoming Investor Conferences
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry